Tumor Markers
Tumor Marker: a biomarker found in the body system that can be elevated by the presence of all types of cancer. Each tumor marker is indicative of a particular disease process, and are used in oncology to help detect the presence of cancer.
OCT 08, 2020
10:00 AM PDT
C.E. CREDITS
OCT 08, 2020
10:00 AM PDT
DATE: October 8, 2020 TIME: 1:00pm PDT Microsatellite instability (MSI) has evolved as a marker of potential hereditary cancer risk and is now a tissue agnostic immune biomarker with a broad...
SEP 15, 2020
8:00 AM PDT
C.E. CREDITS
SEP 15, 2020
8:00 AM PDT
DATE: September 15, 2020 TIME: 08:00am PT Tumorigenesis and cancer progression are affected by the tumor immune microenvironment (TIME). The TIME not only influences the efficiency of existi...
JUN 30, 2020
9:00 AM PDT
C.E. CREDITS
JUN 30, 2020
9:00 AM PDT
DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
JUN 30, 2020
8:00 AM PDT
C.E. CREDITS
JUN 30, 2020
8:00 AM PDT
DATE: June 30, 2020 TIME: 8:00am PT, 11:00am Understanding the tumor microenvironment (TME) is essential for the development of effective treatments for cancer patients. Traditional multi...
JUN 17, 2020
1:30 PM PDT
C.E. CREDITS
JUN 17, 2020
1:30 PM PDT
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
JUN 03, 2020
4:00 PM PDT
C.E. CREDITS
JUN 03, 2020
4:00 PM PDT
The RNAscope in situ hybridization technology allows high sensitivity, specificity and spatial resolution providing pivotal single-cell gene expression information to gain better insights in...
JUN 03, 2020
12:00 PM PDT
C.E. CREDITS
JUN 03, 2020
12:00 PM PDT
A key step in the clinical production of CAR T cells is the expansion of engineered T cells. To generate enough cells for viable adoptive cell therapy, cells must be robustly stimulated, whi...
JUN 03, 2020
9:30 AM PDT
C.E. CREDITS
JUN 03, 2020
9:30 AM PDT
Cancer cells can acquire immune resistance resulting in a loss of immunosurveillance. Tumor cells can upregulate PDL-1 which binds to PD-1. This complex inhibits CD8 Tumor Infiltrating cells...
JUN 03, 2020
6:00 AM PDT
C.E. CREDITS
JUN 03, 2020
6:00 AM PDT
Immune checkpoint therapies targeting the CTLA-4 and PD-(L)1 pathways have been largely clinically disappointing for patients with prostate cancer. This can be attributed to the highly immun...
C.E. CREDITS
Programmed death-1 (PD-1) inhibits T and B cell function upon ligand binding. PD-1 blockade revolutionized cancer treatment, and while numerous patients respond, some develop autoimmune-like...
MAY 14, 2020
3:00 PM CEST
C.E. CREDITS
MAY 14, 2020
3:00 PM CEST
Increasing evidence suggests that targeted sequencing of cell free DNA (cfDNA) can provide a comprehensive molecular portrait of solid tumors. However, the concordance between tissue and cfD...
MAY 12, 2020
9:00 AM PDT
C.E. CREDITS
MAY 12, 2020
9:00 AM PDT
NEW DATE: Date: May 12, 2020 Time: 9:00am PDT, 12:00pm EDT...
MAY 08, 2020
8:00 AM PDT
C.E. CREDITS
MAY 08, 2020
8:00 AM PDT
DATE: May 8, 2020 TIME: 8:00am PT, 11:00am ET Microsatellite instability (MSI) is the condition of genetic hypermutability that results from impaired DNA mismatch repair (MMR). Studies indic...
Background and aim: Multiplexing of biomarker panels by microsphere-based technologies are robust and cost-effective methods. The QuantiGene™ Plex Assay (ThermoFisher Scientific) platf...
